Jar. Pribyl et Tw. Lebien, INTERLEUKIN-7 INDEPENDENT DEVELOPMENT OF HUMAN B-CELLS, Proceedings of the National Academy of Sciences of the United Statesof America, 93(19), 1996, pp. 10348-10353
Mammalian hematopoietic stem cell (HSC) commitment and differentiation
into lymphoid lineage cells proceed through a series of developmental
ly restricted progenitor compartments. A complete understanding of thi
s process, and how it differs from HSC commitment and differentiation
into cells of the myeloid/erythroid lineages, requires the development
of model systems that support HSC commitment to the lymphoid lineages
, We now describe a human bone marrow stromal cell culture that prefer
entially supports commitment and differentiation of human HSC to CD19(
+) B-lineage cells, Fluorescence activated cell sorter-purified CD34(+)/lineage(-) cells were isolated from fetal bone marrow and cultured
on human fetal bone marrow stromal cells in serum-free conditions cont
aining no exogenous cytokines, Over a period of 3 weeks, CD34(++)/line
age(-) cells underwent commitment, differentiation, and expansion into
the B lineage, Progressive changes included: loss of CD34, acquisitio
n of and graded increases in the level of cell surface CD19, and appea
rance of immature B cells expressing mu/kappa or mu/lambda cell surfac
e fg receptors, The tempo and phenotype of B-cell development was not
influenced by the addition of IL-7 (10 ng/ml), or by the addition of g
oat anti-IL-7 neutralizing antibody. These results indicate a profound
difference between mouse and human in the requirement for IL-7 in nor
mal B-cell development, and provide an experimental system to identify
and characterize human bone marrow stromal cell-derived molecules cru
cial for human B lymphopoiesis.